• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

12
results for

"Triglyceride"

Filter

Article category

Keywords

Publication year

Authors

Funded articles

"Triglyceride"

Original Articles
Association between e-cigarette smoking and insulin resistance using the triglyceride-glucose index in Korean adults: Korea National Health and Nutrition Examination Survey
Dahae Lim, Jung In Choi, Ryuk Jun Kwon, Sang Yeoup Lee, Young Hye Cho, Eun Ju Park, Youngin Lee, Sae Rom Lee, Soo Min Son, Yun Jin Kim, Jeong Gyu Lee, Yu Hyeon Yi, Young Jin Tak, Seung Hun Lee, Gyu Lee Kim, Young Jin Ra
Korean J Fam Med 2025;46(5):327-332.   Published online August 20, 2024
DOI: https://doi.org/10.4082/kjfm.23.0141
Background
Insulin resistance contributes to the development of cardiovascular disease and type 2 diabetes mellitus. Smoking leads to an increase in triglyceride levels, which, in turn, increases insulin resistance. Although the number of e-cigarette users has increased in recent years, few studies have investigated the association between ecigarette use and insulin resistance. Therefore, this study aimed to determine the association between e-cigarette use and insulin resistance using the triglyceride-glucose (TyG) index in Korean adults.
Methods
This study included 4,404 healthy adults aged ≥20 years who participated in the Korea National Health and Nutrition Examination Survey between 2019 and 2020. Participants were categorized as never-smokers or ecigarette users, and the TyG index was categorized into low- and high-TyG index groups according to the median value (9.22). A logistic regression analysis was performed to determine the association between e-cigarette smoking and insulin resistance.
Results
E-cigarette users had a higher TyG index than never smokers (e-cigarette: mean=9.35; never: mean=9.18; P<0.001). The ecigarette users had a higher risk of being in the high TyG index group than never-smokers (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.03–1.84). In the subgroup analysis stratified by sex, age, and body mass index, a higher OR for a high TyG index was observed in men (OR, 1.46; 95% CI, 1.03–2.08) and individuals aged 60 years or older (OR, 3.74; 95% CI, 1.14–12.30).
Conclusion
Our findings suggest that e-cigarette use is significantly associated with insulin resistance.

Citations

Citations to this article as recorded by  
  • Association Between Electronic Cigarette Use and Risk of Obstructive Sleep Apnea Among Korean Adults: A Cross-Sectional Nationwide Population-Based Study
    Wonseok Jeong, Min Ji Song, Ji Hye Shin, Ji Hyun Kim
    Journal of Clinical Medicine.2025; 14(11): 3616.     CrossRef
  • Unveiling the risks of noncombustible nicotine or tobacco products
    Su-Min Jeong
    Korean Journal of Family Medicine.2025; 46(5): 297.     CrossRef
  • 7,736 View
  • 129 Download
  • 2 Web of Science
  • 2 Crossref
Non-Insulin-Based Indices of Insulin Resistance for Predicting Incident Albuminuria: A Nationwide Population-Based Study
Hea Lim Choi, Juyeon Yang, Hye Sun Lee, Ji-Won Lee
Korean J Fam Med 2024;45(6):324-330.   Published online March 25, 2024
DOI: https://doi.org/10.4082/kjfm.23.0138
Background
Studies have shown that incident albuminuria is associated with insulin resistance (IR); however, an IR marker that best predicts the prevalence of albuminuria has not yet been established. This study explored the association between IR and incident albuminuria using various IR indices, including the homeostasis model assessment of IR (HOMA-IR), metabolic score for IR (METS-IR), and triglyceride-glucose (TyG) index, and compared their predictive abilities for the prevalence of albuminuria.
Methods
A total of 4,982 Korean adults from the 2019 Korea National Health and Nutritional Examination Survey were analyzed. The odds of albuminuria were determined using the quartiles of the IR indices. Receiver operating characteristic (ROC) curves were used to calculate the area under the ROC curve and predictability. The cutoff values for albuminuria detection were also computed.
Results
An increase in the quartiles of all three IR indices was associated with incident albuminuria, even after full adjustment for covariates (HOMA-IR: odds ratio [OR], 1.906; 95% confidence interval [CI], 1.311–2.772; P=0.006; METS-IR: OR, 2.236; 95% CI, 1.353–3.694; P=0.002; TyG index: OR, 1.757; 95% CI, 1.213–2.544; P=0.003). The area under the ROC curve for incident albuminuria based on the HOMA-IR, METS-IR, and TyG indices was 0.594 (95% CI, 0.568–0.619), 0.633 (95% CI, 0.607–0.659), and 0.631 (95% CI, 0.606–0.656), respectively. The optimal cutoff values for predicting albuminuria were 2.38, 35.38, and 8.72 for the HOMA-IR, METS-IR, and TyG indices, respectively.
Conclusion
The METS-IR and TyG indices outperformed HOMA-IR in predicting incident albuminuria.

Citations

Citations to this article as recorded by  
  • The U-shape relationship between insulin resistance-related indexes and chronic kidney disease: a retrospective cohort study from National Health and Nutrition Examination Survey 2007–2016
    Ruihua Shen, Ling Lin, Zexuan Bin, Xi Qiao
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • 4,208 View
  • 68 Download
  • 1 Web of Science
  • 1 Crossref
A Positive Association between the Atherogenic Index of Plasma and White Matter Hyperintensity
Hyun-Suk Kwon, Jun-Seong Ko, Jun-Hyuk Lee, Kil-Young Kwon, Jee-Hye Han
Korean J Fam Med 2022;43(3):193-198.   Published online May 20, 2022
DOI: https://doi.org/10.4082/kjfm.21.0129
Background
White matter hyperintensity (WMH) is a risk factor for dementia and ischemic stroke. The atherogenic index of plasma (AIP) is a simple and cost-effective marker for the prediction of various vascular diseases. In this study, we evaluated the relationship between AIP and WMH in adults without cerebrovascular accidents.
Methods
We analyzed the data of 281 adults, aged ≥26 years, who underwent brain magnetic resonance imaging (MRI) at the health promotion center of an education hospital between January 2014 and December 2018. Participants were divided into three categories according to tertiles of the AIP scores (T1: <0.20; T2: 0.20–0.48; and T3: >0.48). WMH was defined as a modified Fazekas scale score of 1–3 on brain MRI. A cubic spline curve was used to determine the linearity of the relationship between AIP and WMH. Multiple logistic regression analysis was used to evaluate the relationship between the AIP and WMH.
Results
The prevalence of WMH was 45.7% in T1, 57.0% in T2, and 66.0% in T3 (T3 vs. T1, P for post-hoc analysis=0.005). The increased odds of WMH were associated with increased AIP. The odds ratio (OR) with a 95% confidence interval (CI) for WMH of T2 and T3 compared with T1 were 1.57 (0.88–2.80) and 2.30 (1.28–4.14), respectively. After adjusting for confounding variables, the OR with a 95% CI for WMH in the T2 and T3 groups vs. the referent T1 were 1.55 (0.76–3.13) and 2.27 (1.06–4.84), respectively.
Conclusion
AIP is independently and positively associated with WMH in a healthy population.

Citations

Citations to this article as recorded by  
  • Association between atherogenic index of plasma and dementia: A longitudinal observational study
    Jie Lin, Yan Li, Hao Li
    Journal of Alzheimer’s Disease.2025; 106(1): 197.     CrossRef
  • Relationship between white matter hyperintensity and atherogenic index of plasma in migraine
    Gulhan Sarıcam, Fahrettin Ege, Memet Aslanyavrusu
    Neurological Research.2025; 47(9): 773.     CrossRef
  • The Association Between the Atherogenic Index of Plasma and Cognitive Function: Evidence From the NHANES 2011–2014
    Pingping Huang, Gaocan Ren, Yifei Wang, Yicheng Liu, Hongwei Zhang, Shuangqing Fu, Zhibo Zhang, Lijun Guo, Xiaochang Ma
    Brain and Behavior.2025;[Epub]     CrossRef
  • Triglyceride glucose index and Atherogenic index of plasma for predicting colorectal neoplasms in patients without cardiovascular diseases
    Muzhou Han, Hao Wang, Shuyue Yang, Siying Zhu, Guiping Zhao, Haiyun Shi, Peng Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • 5,312 View
  • 94 Download
  • 4 Web of Science
  • 4 Crossref
The Relationship between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Metabolic Syndrome
Hyun-Gyu Shin, Young-Kwang Kim, Yong-Hwan Kim, Yo-Han Jung, Hee-Cheol Kang
Korean J Fam Med 2017;38(6):352-357.   Published online November 14, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.6.352
Background

Metabolic syndrome is associated with cardiovascular diseases and is characterized by insulin resistance. Recent studies suggest that the triglyceride/high-density lipoprotein cholesterol (TG/HDLC) ratio predicts insulin resistance better than individual lipid levels, including TG, total cholesterol, low-density lipoprotein cholesterol (LDLC), or HDLC. We aimed to elucidate the relationship between the TG/HDLC ratio and metabolic syndrome in the general Korean population.

Methods

We evaluated the data of adults ≥20 years old who were enrolled in the Korean National Health and Nutrition Examination Survey in 2013 and 2014. Subjects with angina pectoris, myocardial infarction, stroke, or cancer were excluded. Metabolic syndrome was defined by the harmonized definition. We examined the odds ratios (ORs) of metabolic syndrome according to TG/HDLC ratio quartiles using logistic regression analysis (SAS ver. 9.4; SAS Institute Inc., Cary, NC, USA). Weighted complex sample analysis was also conducted.

Results

We found a significant association between the TG/HDLC ratio and metabolic syndrome. The cutoff value of the TG/HDLC ratio for the fourth quartile was ≥3.52. After adjustment, the OR for metabolic syndrome in the fourth quartile compared with that of the first quartile was 29.65 in men and 20.60 in women (P<0.001).

Conclusion

The TG/HDLC ratio is significantly associated with metabolic syndrome.

Citations

Citations to this article as recorded by  
  • HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
    Sebastià Alcover, Lisaidy Ramos-Regalado, Gabriela Girón, Natàlia Muñoz-García, Gemma Vilahur
    Antioxidants.2025; 14(4): 434.     CrossRef
  • The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a predictor of NAFLD prevalence and steatosis severity
    Yajie Liu, Ruilin Wang
    Scientific Reports.2025;[Epub]     CrossRef
  • The systemic toxicity of intravitreally injected gold nanorods in mice: Effects of size, surface conjugation, and post-injection period
    Hafithe M. AlGhosain, Jiarui Nie, Tao Liu, Jonghwan Lee
    Toxicological Research.2025; 41(5): 489.     CrossRef
  • Metabolic syndrome and related factors in Cameroonian women under contraceptive use
    Dandji Saah Marc Bertrand, Dangang Bossi Donald Séverin, Tanguenan Floraise Lynda, Zambou Ngoufack François, Ibrahim Sebutu Bello
    PLOS ONE.2024; 19(11): e0309054.     CrossRef
  • Association Between Triglycerides, High-Density Lipoprotein Cholesterol, and Their Ratio With the Pulse Wave Velocity in Adults From the ELSA-Brasil Study
    Deborah de Farias Lelis, Roberto S. Cunha, Raul D. Santos, Andrei C. Sposito, Rosane Härter Griep, Sandhi Maria Barreto, Maria del Carmen B. Molina, Maria Inês Schmidt, Bruce B. Duncan, Isabela Bensenor, Paulo Andrade Lotufo, José Geraldo Mill, Marcelo Pe
    Angiology.2023; 74(9): 822.     CrossRef
  • The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
    Constantine E. Kosmas, Shanna Rodriguez Polanco, Maria D. Bousvarou, Evangelia J. Papakonstantinou, Edilberto Peña Genao, Eliscer Guzman, Christina E. Kostara
    Diagnostics.2023; 13(5): 929.     CrossRef
  • The Association between the Atherogenic Index of Plasma and Cardiometabolic Risk Factors: A Review
    Beatrice Lioy, Richard James Webb, Farzad Amirabdollahian
    Healthcare.2023; 11(7): 966.     CrossRef
  • Serum Asprosin Correlates with Indirect Insulin Resistance Indices
    Małgorzata Mirr, Anna Braszak-Cymerman, Aleksandra Ludziejewska, Matylda Kręgielska-Narożna, Paweł Bogdański, Wiesław Bryl, Maciej Owecki
    Biomedicines.2023; 11(6): 1568.     CrossRef
  • Lipid accumulation product is a better predictor of metabolic syndrome in Chinese adolescents: a cross-sectional study
    Zi-yi Chen, Lei Liu, Xu-xiu Zhuang, Yi-cong Zhang, Ya-nan Ma, Yang Liu, De-liang Wen
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Relationship between night shift and sleep problems, risk of metabolic abnormalities of nurses: a 2 years follow-up retrospective analysis in the National Nurse Health Study (NNHS)
    Heli Zhang, Jingpin Wang, Siwei Zhang, Sumei Tong, Jinping Hu, Ying Che, Lin Zhuo, Peng Wang, Rongmei Geng, Yujie Zhou, Panfeng Wang, Siyan Zhan, Baohua Li
    International Archives of Occupational and Environmental Health.2023; 96(10): 1361.     CrossRef
  • Association between Triglycerides to High-Density Lipoprotein Cholesterol Ratio and Death Risk in Diabetic Patients with New-Onset Acute Coronary Syndrome: A Retrospective Cohort Study in the Han Chinese Population
    Dongdong Shi, Le Wang, Hongliang Cong
    Reviews in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
    Le Wang, Hongliang Cong, Jingxia Zhang, Yuecheng Hu, Ao Wei, Yingyi Zhang, Hua Yang, Libin Ren, Wei Qi, Wenyu Li
    Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
  • Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study
    Deborah de Farias Lelis, João Vitor S. Calzavara, Raul D. Santos, Andrei C. Sposito, Rosane Härter Griep, Sandhi Maria Barreto, Maria del Carmen B. Molina, Maria Inês Schmidt, Bruce B. Duncan, Isabella Bensenor, Paulo Andrade Lotufo, José Geraldo Mill, Ma
    Journal of Clinical Lipidology.2021; 15(5): 699.     CrossRef
  • Triglyceride to high density lipoprotein cholesterol ratio may serve as a useful predictor of major adverse coronary event in female revascularized ST-elevation myocardial infarction
    Guo-xing Wan, Wen-bin Xia, Li-hua Ji, Hai-lun Qin, Yong-gang Zhang
    Clinica Chimica Acta.2018; 485: 166.     CrossRef
  • Triglyceride to high density lipoprotein cholesterol ratio among adolescents is associated with adult hypertension: the Kangwha study
    Hyungseon Yeom, Hyeon Chang Kim, Ju-Mi Lee, Yongwoo Jeon, Il Suh
    Lipids in Health and Disease.2018;[Epub]     CrossRef
  • 7,596 View
  • 64 Download
  • 18 Web of Science
  • 15 Crossref
Serum Lipid Levels in Relation to Consumption of Yogurt: The 2012 Korea National Health and Nutrition Examination Survey
Bong-Kyung Seo, Nam-Eun Kim, Kyong-Min Park, Kye-Yeung Park, Hoon-Ki Park, Hwan-Sik Hwang
Korean J Fam Med 2017;38(5):249-255.   Published online September 22, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.5.249
Background

The purpose of this study was to evaluate serum lipid levels in Korean adults after consumption of different types of yogurt.

Methods

Study subjects were 3,038 individuals (≥19 years of age) who participated in the 2012 Korean National Health and Nutrition Examination Survey. Yogurt intake was assessed with a food frequency questionnaire by using the 24-hour recall method. We conducted complex samples general linear analysis with adjustment for covariates.

Results

The serum triglyceride levels in the group consuming viscous yogurt were lower than those in the group consuming non-viscous yogurt.

Conclusion

Consumption of viscous yogurt is associated with low serum triglyceride levels in Korean adults.

Citations

Citations to this article as recorded by  
  • Comparison and effect of plain and calcium fortified yogurt on glycemic responses, anthropometrics and metabolic biomarkers
    Asma Draz, Hafiza Madiha Jaffar, Bahisht Rizwan, Sadia Sukhera, Syeda Aiman Batool, Sana Noreen, Nazia Koser, Zeenat Islam
    Immunological Medicine.2024; 47(1): 30.     CrossRef
  • Effect of Yogurt Consumption on Metabolic Syndrome Risk Factors: a Narrative Review
    Leila Khorraminezhad, Iwona Rudkowska
    Current Nutrition Reports.2021; 10(1): 83.     CrossRef
  • 5,615 View
  • 54 Download
  • 2 Web of Science
  • 2 Crossref
Effect of Fenofibrate Medication on Renal Function
Sungjong Kim, Kyungjin Ko, Sookyoung Park, Dong Ryul Lee, Jungun Lee
Korean J Fam Med 2017;38(4):192-198.   Published online July 20, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.4.192
Background

Fibrates are widely used to treat hypertriglyceridemia, a risk factor for arteriosclerosis, but these compounds have been associated with renal dysfunction. This study aimed to investigate the effects of fibrates on renal function in relatively healthy adult subjects with no cardiovascular diseases.

Methods

This retrospective study included 558 outpatients who were prescribed 160 mg fenofibrate (fenofibrate group) or 10 mg atorvastatin (control group) between August 2007 and October 2015. The groups were randomly matched using propensity scores at a 1:1 ratio. Serum creatinine levels and estimated glomerular filtration rates before and after treatment were compared between the two groups.

Results

Patients in the fenofibrate group showed greater changes in serum creatinine levels than those in the control group (9.73%±9.83% versus −0.89%±7.37%, P<0.001). Furthermore, 55.1% of patients in the fenofibrate group, but only 6.1% of those in the control group, exhibited a serum creatinine level increase ≥0.1 mg/dL (P<0.001). The fenofibrate group showed significantly greater declines in the estimated glomerular filtration rate than the control group (−10.1%±9.48% versus 1.42%±9.42%, P<0.001). Moreover, 34.7% of the fenofibrate group, but only 4.1% of the control group, exhibited an estimated glomerular filtration rate decrease ≥10 mL/min·1.73 m2 (P<0.001).

Conclusion

Fenofibrate treatment resulted in increased serum creatinine levels and reduced estimated glomerular filtration rates in a primary care setting. Therefore, regular renal function monitoring should be considered essential during fibrate administration.

Citations

Citations to this article as recorded by  
  • An interracial Mendelian analysis revealed a link between lipid‐lowering drugs and renal failure
    Naidan Zhang, Chaixia Ji, Baibing Xie, Yaoyang Liu, Chengliang Yuan
    Lipids.2025; 60(4): 173.     CrossRef
  • Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
    Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, Nami Mori, Shintaro Takaki, Kazuki Ohya, Toshie Mashiba, Hironori Ochi, Haruhiko Kobashi, Chikara Ogawa, Michiko Nonogi, Hideo Yoshida, Takehiro Akahane, Masahiko Kondo, Toyotaka Kasai, Hideki Fujii, Yasush
    Hepatology Research.2025; 55(5): 675.     CrossRef
  • Fenofibrate-Induced Osmotic Nephropathy: A Novel Mechanism of Acute Kidney Injury
    Raymond Lin, Seethalakshmi Viswanathan, Nikki L. Wong
    American Journal of Kidney Diseases.2025; 86(3): 404.     CrossRef
  • Fenofibrate Differently Affects the Heart’s Morphology and Metabolism in Young and Old Rats
    Agata Wrońska, Jacek Kieżun, Zbigniew Kmieć
    International Journal of Molecular Sciences.2025; 26(16): 8038.     CrossRef
  • Role of nuclear receptors, lipid metabolism, and mitochondrial function in the pathogenesis of diabetic kidney disease
    Eleni Hughes, Xiaoxin X. Wang, Lily Sabol, Keely Barton, Sujit Hegde, Komuraiah Myakala, Ewa Krawczyk, Avi Rosenberg, Moshe Levi
    American Journal of Physiology-Renal Physiology.2025; 329(4): F510.     CrossRef
  • Identifikasi Drug Related Problems (DRPs) Pada Pasien Penyakit Ginjal Kronis di Instalasi Rawat Inap Rumah Sakit X Surakarta Tahun 2024
    Afrizal Mubarok, Tista Ayu Fortuna
    Journal of Pharmaceutical and Sciences.2025; : 2208.     CrossRef
  • Characterizing Fenofibrate-Related Renal and Urinary Adverse Events: A Comprehensive Analysis of FDA Adverse Event Reporting System Database
    Li Wang, Xiangyun Jin, YanChun Li
    Clinical Therapeutics.2025;[Epub]     CrossRef
  • Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver
    Venkat R. Pannala, Michele R. Balik-Meisner, Deepak Mav, Dhiral P. Phadke, Elizabeth H. Scholl, Ruchir R. Shah, Warren Casey, Scott S. Auerbach, Anders Wallqvist
    Scientific Reports.2025;[Epub]     CrossRef
  • Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation
    Meng Wang, Jing Wang, Lingchen Wang, Xiaoxuan Feng, Yiling Qian, Chaoyang Ye, Chen Wang
    Phytotherapy Research.2024; 38(2): 839.     CrossRef
  • Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys
    Meng Wang, Lingchen Wang, Liang Zhou, Yizeng Xu, Chen Wang
    Phytomedicine.2024; 126: 155450.     CrossRef
  • Frequency and predictors of inappropriate medication dosages for cardiovascular disease prevention in chronic kidney disease patients: A retrospective cross-sectional study in a Malaysian primary care clinic
    Jazlan Jamaluddin, Mohamed-Syarif Mohamed-Yassin, Siti Nuradliah Jamil, Mohd Azzahi Mohamed Kamel, Mohamad Ya'akob Yusof
    Heliyon.2023; 9(4): e14998.     CrossRef
  • Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial
    Rene Rodriguez-Gutierrez, Jose Gerardo González, Deven Parmar, Farheen. Shaikh, Pio Cruz-López
    Journal of Lipid Research.2022; 63(7): 100233.     CrossRef
  • PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH)
    Simona Todisco, Anna Santarsiero, Paolo Convertini, Giulio De Stefano, Michele Gilio, Vito Iacobazzi, Vittoria Infantino
    Biology.2022; 11(5): 792.     CrossRef
  • Three-dimensional electrochemical degradation of p-aminophenol with efficient honeycomb block AC@Ti-Cu-Ni-Zn-Sb-Mn particle electrodes
    Jia Wan, Feiping Zhao, Yong Meng, Mengyan Guo, Chong-jian Tang, Yan Shi, Yong Ke, Rong Hu
    Separation and Purification Technology.2021; 267: 118662.     CrossRef
  • Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
    Yohei Tomita, Deokho Lee, Kazuo Tsubota, Kazuno Negishi, Toshihide Kurihara
    Journal of Clinical Medicine.2021; 10(20): 4666.     CrossRef
  • Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
    Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada
    The Korean Journal of Gastroenterology.2021; 78(4): 227.     CrossRef
  • Drug Therapies Affecting Renal Function: An Overview
    Reem Y Alhassani, Reem M Bagadood, Rafal N Balubaid, Haneen I Barno, Mariah O Alahmadi, Nahla A Ayoub
    Cureus.2021;[Epub]     CrossRef
  • Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases
    Hee-Seong Jang, Mi Ra Noh, Jinu Kim, Babu J. Padanilam
    Frontiers in Medicine.2020;[Epub]     CrossRef
  • Fenofibrate-induced renal dysfunction, yes or no?
    Fatemeh Emami, Amirali Hariri, Mohammad Matinfar, Mehdi Nematbakhsh
    Journal of Research in Medical Sciences.2020; 25(1): 39.     CrossRef
  • PPARα Agonist Oral Therapy in Diabetic Retinopathy
    Yohei Tomita, Deokho Lee, Kazuo Tsubota, Toshihide Kurihara
    Biomedicines.2020; 8(10): 433.     CrossRef
  • Dyslipidemia in patients with chronic kidney disease: etiology and management
    Magdaléna Dušejovská, Marek Vecka, Ivan Rychlík, Aleš Žák
    Vnitřní lékařství.2020; 66(5): 275.     CrossRef
  • Lipid-lowering and antioxidative effects ofApium graveolensL. root flavonoid extracts
    Yuan He, Yang Shi, Airong Zhang, Xiaoxia Zhang, Jing Sun, Li Tian
    RSC Advances.2019; 9(46): 26757.     CrossRef
  • Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
    Hong Sheng Cheng, Wei Ren Tan, Zun Siong Low, Charlie Marvalim, Justin Yin Hao Lee, Nguan Soon Tan
    International Journal of Molecular Sciences.2019; 20(20): 5055.     CrossRef
  • 8,162 View
  • 88 Download
  • 22 Web of Science
  • 23 Crossref
Background

We studied the association between the triglyceride to high-density lipoprotein cholesterol ratio and computed tomography-measured visceral fat as well as cardiovascular risk factors among Korean male adults.

Methods

We measured triglycerides, high density lipoprotein cholesterol, body mass, waist circumference, fasting plasma glucose, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, visceral fat, and subcutaneous fat among 372 Korean men. The visceral fat and subcutaneous fat areas were measured by computed tomography using a single computed tomography slice at the L4-5 lumbar level. We analyzed the association between the triglyceride to high density lipoprotein cholesterol ratio and visceral fat as well as cardiovascular risk factors.

Results

A positive correlation was found between the triglyceride to high density lipoprotein cholesterol ratio and variables such as body mass index, waist circumference, fasting plasma glucose, hemoglobin A1c, visceral fat, and the visceral-subcutaneous fat ratio. However, there was no significant correlation between the triglyceride to high density lipoprotein cholesterol ratio and subcutaneous fat or blood pressure. Multiple logistic regression analyses revealed significant associations between a triglyceride to high density lipoprotein cholesterol ratio ≥3 and diabetes, a body mass index ≥25 kg/m2, a waist circumference ≥90 cm, and a visceral fat area ≥100 cm2. The triglyceride to high density lipoprotein cholesterol ratio was not significantly associated with hypertension.

Conclusion

There were significant associations between the triglyceride to high density lipoprotein cholesterol ratio and body mass, waist circumference, diabetes, and visceral fat among a clinical sample of Korean men. In the clinical setting, the triglyceride to high density lipoprotein cholesterol ratio may be a simple and useful indicator for visceral obesity and cardiovascular disease.

Citations

Citations to this article as recorded by  
  • The impact of serum testosterone level to reflect age-related multi-organ functions
    Tomoya Shirakawa, Julius Fink, Zen-u Hotta, Yosuke Shimada, Yan Lu, Junhua Du, Kazuhito Matsushita, Satoshi Hori, Hisamitsu Ide, Shigeo Horie
    Endocrine Journal.2024; 71(3): 265.     CrossRef
  • Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment—A Single-Group Repeated-Measures Trial
    Mengnan Li, Xifeng Yang, Ru Li, Baofeng Wu, Jinxuan Hao, Yijie Qi, Tao Bai, Luyang Yang, Yi Zhang, Yunfeng Liu
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2165.     CrossRef
  • Prognostic nomograms integrating preoperative serum lipid derivative and systemic inflammatory marker of patients with non-metastatic colorectal cancer undergoing curative resection
    Dimei Huang, Shaochu Zheng, Fang Huang, Jingyu Chen, Yuexiang Zhang, Yusha Chen, Bixun Li
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis
    Parham Mardi, Fatemeh Abdi, Amir Ehsani, Ehsan Seif, Shirin Djalalinia, Javad Heshmati, Ehsan Shahrestanaki, Armita Mahdavi Gorabi, Mostafa Qorbani
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Factors associated with hypertriglyceridemia among the hill tribe people aged 30 years and over, Thailand: a cross-sectional study
    Panupong Upala, Tawatchai Apidechkul, Chanyanut Wongfu, Siriyaporn Khunthason, Niwed Kullawong, Vivat Keawdounglek, Chalitar Chomchoei, Fartima Yeemard, Ratipark Tamornpark
    BMC Public Health.2021;[Epub]     CrossRef
  • Independent association between the visceral adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes
    Jia Wen, Hong Yuan
    Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
  • Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community dwelling adults: A longitudinal 12-year analysis of the Korean Genome and Epidemiology Study
    Tae-Kyeong Lim, Hye Sun Lee, Yong-Jae Lee
    Diabetes Research and Clinical Practice.2020; 163: 108150.     CrossRef
  • Association of triglycerides to high-density lipoprotein-cholesterol ratio with risk of incident hypertension
    Dechen Liu, Li Guan, Yang Zhao, Yu Liu, Xizhuo Sun, Honghui Li, Zhaoxia Yin, Linlin Li, Yongcheng Ren, Bingyuan Wang, Cheng Cheng, Leilei Liu, Xu Chen, Qionggui Zhou, Quanman Li, Chunmei Guo, Gang Tian, Ming Zhang, Dongsheng Hu, Jie Lu
    Hypertension Research.2020; 43(9): 948.     CrossRef
  • Visceral adiposity index is associated with increased urinary albumin excretion: A population-based study
    Kan Sun, Diaozhu Lin, Feng Li, Yiqin Qi, Wanting Feng, Meng Ren, Li Yan, Dan Liu
    Clinical Nutrition.2019; 38(3): 1332.     CrossRef
  • The correlation between triglyceride to HDL cholesterol ratio and metabolic syndrome, nutrition intake in Korean adults: Korean National Health and Nutrition Examination Survey 2016
    Youngjon Kim, A Lum Han
    Journal of Nutrition and Health.2019; 52(3): 268.     CrossRef
  • An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: The FIESTA study
    Feng Peng, Dan Hu, Xiandong Lin, Gang Chen, Binying Liang, Ying Chen, Chao Li, Hejun Zhang, Yan Xia, Jinxiu Lin, Xiongwei Zheng, Wenquan Niu
    Cancer Epidemiology.2018; 52: 148.     CrossRef
  • Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study
    Dan Hu, Feng Peng, Xiandong Lin, Gang Chen, Binying Liang, Ying Chen, Chao Li, Hejun Zhang, Guohui Fan, Guodong Xu, Yan Xia, Jinxiu Lin, Xiongwei Zheng, Wenquan Niu
    BMC Cancer.2018;[Epub]     CrossRef
  • Risk for metabolic diseases in normal weight individuals with visceral fat accumulation: a cross-sectional study in Japan
    Yukako Tatsumi, Yoko M Nakao, Izuru Masuda, Aya Higashiyama, Misa Takegami, Kunihiro Nishimura, Makoto Watanabe, Takayoshi Ohkubo, Tomonori Okamura, Yoshihiro Miyamoto
    BMJ Open.2017; 7(1): e013831.     CrossRef
  • ‘Life in the age of screens’: parent perspectives on a 24‐h no screen‐time challenge
    Sandra Peláez, Stephanie Alexander, Jean‐Baptiste Roberge, Melanie Henderson, Jean‐Luc Bigras, Tracie A. Barnett
    Clinical Obesity.2016; 6(4): 273.     CrossRef
  • Pereskia aculeata Miller Flour: Metabolic Effects and Composition
    Sandra Maria Barbalho, Élen Landgraf Guiguer, Paulo Sérgio Marinelli, Patrícia Cincotto do Santos Bueno, Leticia Maria Pescinini-Salzedas, Mirele Cristine Batista dos Santos, Marie Oshiiwa, Claudemir Gregório Mendes, Manoel Lima de Menezes, Cláudia Cristi
    Journal of Medicinal Food.2016; 19(9): 890.     CrossRef
  • Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men with Late-Onset Hypogonadism
    Sompol Permpongkosol, Kalayanee Khupulsup, Supatra Leelaphiwat, Sarawan Pavavattananusorn, Supranee Thongpradit, Thanom Petchthong
    The Journal of Sexual Medicine.2016; 13(8): 1199.     CrossRef
  • 5,576 View
  • 45 Download
  • 16 Web of Science
  • 16 Crossref
Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome
Tae-Heum Chung, Moon-Chan Kim, Chang-Sup Kim
Korean J Fam Med 2014;35(2):81-89.   Published online March 24, 2014
DOI: https://doi.org/10.4082/kjfm.2014.35.2.81
Background

Infection with hepatitis B virus (HBV) may be a risk factor for cardiovascular disease. We investigated the relationship between HBV infection and metabolic syndrome.

Methods

We performed a cross-sectional study of 9,474 Korean men and women who were at least 20 years old and who underwent a routine health check-up at Ulsan University Hospital in Ulsan, South Korea between March 2008 and February 2009. The associations of hepatitis B surface antigen (HBsAg) seropositivity with the presence of metabolic syndrome and its components were investigated by logistic regression analysis. Data were analyzed separately for males and females.

Results

HBsAg seropositivity was significantly negatively associated with hypertriglyceridemia and metabolic syndrome in men (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.29 to 0.50; P < 0.001 and OR, 0.75; 95% CI, 0.57 to 0.98, P = 0.033). In women, HBsAg seropositivity was also significantly negatively associated with hypertriglyceridemia, but not with metabolic syndrome (OR, 0.40; 95% CI, 0.17 to 0.91; P = 0.029 and OR, 0.80; 95% CI, 0.38 to 1.66, P = 0.545).

Conclusion

HBV infection was significantly negatively associated with hypertriglyceridemia and metabolic syndrome in men and hypertriglyceridemia in women.

Citations

Citations to this article as recorded by  
  • Systematic review: chronic viral hepatitis and metabolic derangement
    Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao
    Alimentary Pharmacology & Therapeutics.2020; 51(2): 216.     CrossRef
  • Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome
    Edina Amponsah-Dacosta, Cynthia Tamandjou Tchuem, Motswedi Anderson
    World Journal of Virology.2020; 9(5): 54.     CrossRef
  • Canonical Correlation Between Self-Care Agency and Health-Related Self-Efficacy with Chronic Viral Hepatitis Patients
    HooJeung Cho, Euna Park
    Osong Public Health and Research Perspectives.2019; 10(5): 281.     CrossRef
  • Association between chronic hepatitis B infection and metabolic syndrome
    Xiaohui Zhao, Drishti Shah, Usha Sambamoorthi
    Journal of Diabetes & Metabolic Disorders.2018; 17(2): 223.     CrossRef
  • Hepatitis‐Viral

    Journal of Gastroenterology and Hepatology.2017; 32(S2): 65.     CrossRef
  • Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based Study
    Cheng-Hung Chien, Li-Wei Chen, Chih-Lang Lin, Su-Wie Chang, Yu-Chiau Shyu, Kuan-Fu Chen, Shuo-Wei Chen, Ching-Chih Hu, Chia-Ying Yu, Rong-Nan Chien
    Scientific Reports.2017;[Epub]     CrossRef
  • Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis
    Yuanyuan Li, Ying Zhao, Jianping Wu, Ferruccio Bonino
    PLOS ONE.2017; 12(5): e0177713.     CrossRef
  • Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF45-like effectors
    Jun Yasumoto, Hirotake Kasai, Kentaro Yoshimura, Teruhime Otoguro, Koichi Watashi, Takaji Wakita, Atsuya Yamashita, Tomohisa Tanaka, Sen Takeda, Kohji Moriishi
    Journal of General Virology .2017; 98(7): 1762.     CrossRef
  • Association of chronic hepatitis B infection with metabolic syndrome and its components: Meta-analysis of observational studies
    Bahman Razi, Shahab Alizadeh, Azadeh Omidkhoda, Danyal Imani, Ramazan Rezaei
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017; 11: S939.     CrossRef
  • Occult Hepatitis B Virus Infection in Hyperlipidemia Patients
    Liu Yang, Tingting Li, Wenmin Li, Xi Tang, Jinfeng Li, Ruiwen Long, Yongshui Fu, Jean-Pierre Allain, Chengyao Li
    The Tohoku Journal of Experimental Medicine.2017; 241(4): 255.     CrossRef
  • Prevalence of metabolic syndrome among adults with liver function injury in rural area of Southwest China: A cross-sectional study
    Hui Zeng, Hui Lin, Wenyi Liu, Jia Wang, Lingqiao Wang, Chuanfen Zheng, Yao Tan, Yujing Huang, Lixiong He, Jiaohua Luo, Chaowen Pu, Renping Zhang, Xiaohong Yang, Yingqiao Tian, Zhiqun Qiu, Ji-an Chen, Yang Luo, Xiaobin Feng, Guosheng Xiao, Liping Wu, Weiqu
    Scientific Reports.2017;[Epub]     CrossRef
  • Association between hepatitis B and metabolic syndrome: Current state of the art
    Peter Jarcuska
    World Journal of Gastroenterology.2016; 22(1): 155.     CrossRef
  • Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach
    Chiao‐Yu Huang, Chia‐Wen Lu, Yi‐Lien Liu, Chien‐Hsieh Chiang, Long‐Teng Lee, Kuo‐Chin Huang
    Obesity.2016; 24(2): 483.     CrossRef
  • Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome
    Aezam Katoonizadeh, Shima Ghoroghi, Maryam Sharafkhah, Masoud Khoshnia, Samaneh Mirzaei, Amaneh Shayanrad, Hossein Poustchi, Reza Malekzadeh
    Journal of Medical Virology.2016; 88(7): 1230.     CrossRef
  • Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
    Chia‐Chi Wang, Tai‐Chung Tseng, Jia‐Horng Kao
    Journal of Gastroenterology and Hepatology.2015; 30(1): 14.     CrossRef
  • 5,236 View
  • 25 Download
  • 13 Web of Science
  • 15 Crossref
The Effect of Atorvastatin on Serum Lipid Levels among Patients with Hypercholesterolemia.
Sang Sung John, Jae Hyung Park, Hyun Joo Chung, Jung Cheon Son, Kwang Min Kim, Bom Taeck Kim
J Korean Acad Fam Med 2004;25(1):46-51.   Published online January 10, 2004
Background
: Recently, the incidence of cardiovascular diseases has increased in Korea. Hypercho-lesterolemia is a major risk factor for cardiovascular diseases. Atorvastatin (Lipitor±) is prescribed for the treatment of hyperlipidemia in Korea, but its effect has not been studied. Therefore, we investigated the lipid lowering effect of atorvastatin in Koreans.

Methods : This study included 82 hypercholesterolemic patients who visited the Department of Family Practice of Ajou University Hospital from January 1, 2000 to December 31, 2001. The mean age of the subjects was 47.8 years in the range of 27 to 66 years. Our study included 41 controls and 41 subjects who were administered atorvastatin 20 mg daily for 3 months. Fasting serum lipid levels were measured at baseline and at 3 months. Specific dietary and exercise interventions were not instructed.

Results : At 3 months, the serum total cholesterol and LDL were significantly lower in atorvastatin group than in the control group (Total cholesterol; -5.5±16.7%, vs 25.5±15.8%, P<0.05, LDL cholesterol; 1.4±28.5%, vs -30.1±28.9%, P<0.05). The serum triglyceride in atorvastain group showed no significant difference relative to the controls (Control: -5.8±34.2%, Atorvastatin: -3.5±54.8%, P=0.81). But, Serum triglyceride level decreased by -14.3±33.2% in the control and -39.0±23.2% in the atorvastatin group among the patients whose baseline triglyceride level was over 200 mg/dl (P<0.05). There was no significant differences in HDL-cholesterol (Control: 3.0±22.6%, Atorvastatin: -0.9±18.8%, P=0.38). The effect of atorvastatin was not influenced by age, sex, BMI and other risk factors.

Conclusion : Atorvastatin lowered significantly the serum total cholesterol, LDL and triglycerides in Korea. Regardless of age, sex, BMI, but had no effect on HDL level.
  • 1,615 View
  • 26 Download
Profile of serum lipoprotein in patients with subclinical hypothyroidism.
Wou Weon Lee, Chung Hwan Kim, Yoo Seock Cheong, Sun Mi Yoo, Il Hwan Park, Seouk Gun Park
J Korean Acad Fam Med 2000;21(3):376-381.   Published online March 1, 2000
Background
: Overt hyperthyroidism is a well-known cause of secondary hyperlipidemia and atherosclerosis. However, there have been some dissenting report of abnormalities and in serum lipid concentration in patients with subclinical hypothyroidism. We have attempted to analyze serum lipid concentrations to investigate whether they are increased in patients with subclinical hypothyroidism and to see if there is a correlation between serum LDL-C and TSH concentrations.

Methods : Serum lipid profiles(total cholesterol, triglycerides, LDL-C, HDL-C) of patients with subclinical hypothyroidism (M/F=7/119) compared with age, sex and body mass index matched control subject(M/F=14/239) from Jan. 1. 1996. to Dec. 30. 1997.

Results : There were no significant differences of serum total cholesterol, LDL cholesterol, TG, and HDL concentrations in 126 patients with subclinical hypothyroidism and 253 control subjects(178.47±35.76mg/Dl vs. 173.05±35.963mg/Dl ; 113.33±52.89mg/Dl vs.117.64±68.70mg/Dl ; 112.89±33.25mg/dL vs 109.65±29.02mg/Dl ; 48.60±11.34mg/Dl vs 46.51±11.73mg/Dl). There was no correlation between LDL cholesterol and TSH concentrations in subclinical hypothyroidism(r=0.29, p<0.05).

Conclusion : Serum lipid concentration(total cholesterol, LDL cholesterol, and TG, HDL) was not increased in patients with subclinical hypothyroidism. There was no correlation between serum LDL and TSH levels in patients with subclinical hypothyroidism.
  • 1,472 View
  • 9 Download
The Effects of Alcohol On the Serum Lipid Level of Healthy Adutss.
Seon Young Kwon, Jung Jin Cho, Hoon Ill Kang
J Korean Acad Fam Med 1999;20(10):1260-1268.   Published online October 1, 1999
Background
: It has been reported that hypercholesterolemia is associated with coronary heart disease and that alcohol intake influence on the lipid metabolism. This study was conducted to evaluate the relations between alcohol intake and serum lipid level.

Methods : We reviewed 906 subjects who had visited for routine checkup at family practice of Hanil hospital and then excluded 130 subjects with DM, renal disease, thyroid disease, hepatic disease or drug administration which might have influence on serum lipids. From the remaining 776 subjects, we obtained the amount and the frequency of alcohol drinking during the previous 2 weeks and the duration of alcohol intake, using a formed questionnaire. The alcohol dependence score was recorded by the National Alcoholism Screening Test. The serum lipids such as total cholesterol, triglyceride, and HDL-cholesterol were tested by enzyme method and obesity index was obtained by Broca’s methods. These data were analyzed by SAS/TC program.

Results : The total number of subjects was 776. Of those, 67.7% (n=525) were male and 32.3%(n=25) females. The mean age of subjects was 50.5 years (range 15 to 77 years). The distribution according to the obesity index was as follows; underweight group 7.1%, normal-weight group 38.1%, over-weight group 31.6%, obesity group 23.2%. The number of the drinkers was 382(49.2%) in males and 7(0.9%) in females.
The mean serum lipid level were compared and analyzed among the groups. The results were as follows; the total cholesterol and triglyceride levels were higher in males and the HDL-cholesterol levels was higher in females. The total cholesterol and triglyceride levels increased with age and obesity index, the HDL-cholesterol level decreased with obesity index. In the relationship between alcohol intake and serum lipid levels in males, The geometric mean of triglyceride level was higher among all the variables of alcohol intake, and the HDL-cholesterol level increased with the amount and the frequency of alcohol intake.
The results of multiple regression analysis associated with age, obesity, index, the amount and the frequency of alcohol intake in males were as follows; the triglyceride level was positively associated with the amount of alcohol intake, and the HDL-cholesterol level was positively associated with the frequency of alcohol intake.

Conclusion : The effects of age, sex and the obesity index on the serum lipid level are remarkable, and in males, alcohol intake increases triglyceride and HDL-cholesterol levels. Further study is needed to find out about whether alcohol intake have influences on coronary heart disease according to serum lipid levels.
  • 1,361 View
  • 10 Download
The Factors Associated with Serum Triglyceride Level in Healthy Adults.
Hyoyee Jeon, Belong Cho, Young Ho Yun, Taiwoo Yoo, Bongyul Huh
J Korean Acad Fam Med 1998;19(1):29-42.   Published online January 1, 1998
Background
: Previously, a large epidemiological study has found that an increase in the serum triglyceride level is an independent risk factor of coronary artery disease and by treating it, the mortality due to coronary artery disease could be decreased. Our study is designed to analyze the serum triglyceride level in healthy adults and to study various factors influencing the serum triglyceride level.

Methods : Study involved all patients who visited Seoul National University Hospital Health Promotion Center from May 1995 to Feb 1997. After a complete history and a physical examination, each participant answered a questionnaire involving sociodemographics, tobacco, alcohol, exercise, menstrual cycle and daily dietary contents. A blood chemistry was also drawn after 12 hours of fasting. We used analysis of covariance and multiple regression analysis to correlate triglyceride level with forementioned variables.

Results : Healthy 3,332 men and 2,986 women were statistically analyzed. The average triglyceride level was 110.7mg/dl(geometric mean). Men at 50's had the highest level of triglyceride. As women aged, their triglyceride level increased. The proportion of participants in their 40's in men and 70's and over in women with triglyceride >220mg/dl, a value of clinical importance, was 19.0% and 18.4%, respectively. The triglyceride level changed significantly according to BMI, exercise, physical fitness, alcohol, tobacco, blood pressure, uric acid and glucose. However, no statistically significant difference was found among diet, thyroid function, income and region. For men, a multiple regression analysis revealed that the factors influencing triglyceride level in decreasing order, were BMI, uric acid, tobacco, diastolic blood pressure, ALT and maximal oxygen uptake. However, for women, a similar analysis showed that BMI, systolic blood pressure, exercise, tobacco and age played a significant role(p<0.001).

Conclusion : Serum triglyceride level was associated with correctable behavioral factors such as obesity, smoking, alcohol, exercise, and physical fitness. Among these factors obesity was the most related factor with triglyceride level.
  • 1,499 View
  • 16 Download
TOP